PRESS RELEASESMBS Inks Deal with Canon BioMedical for NEXTGENPCR distribution in US and Canada24 April 2018Dutch biotechnology company Molecular Biology Systems (MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler in the US and Canada through Canon BioMedical, Inc., a wholly owned subsidiary of Canon U.S.A., Inc. focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions.... Read more...NEXTGENPCR Steals the Show at ESHG and LABVOLUTION10 July 2017Superfast cycler stuns genomics community with sub-2 minute protocols. Dutch biotechnology company Molecular Biology Systems(MBS) today reported major interest for its revolutionary NEXTGENPCR thermal cycler following the appearance of the first production models at the recent ESGH and LABVOLUTION meetings.... Read more...MBS seals exclusive NEXTGENPCR distributorship with Isogen Life Science for Benelux and Spain8 July 2017Demand grows for superfast cycler after LABVOLUTION and ESHG showing. Dutch biotechnology company Molecular Biology Systems(MBS) today announced it has signed an exclusive distributor agreement for its revolutionary NEXTGENPCR thermal cycler with Isogen Life Sciences. This follows highly successful showings of the first production models at the recent ESHG and LABVOLUTIONS meetings.... Read more...
